Wilson Sonsini Goodrich & Rosati advised Vertos Medical Inc. on the transaction. Stryker (NYSE: SYK), a global leader in medical technologies, announced a definitive agreement to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction. Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Mobile Health on the transaction, while Paul Hastings and Bass, Berry & Sims advised H.I.G. Growth Partners. H.I.G. Growth Partners...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. is advising Yext on the transaction, and Latham & Watkins is advising Hearsay Systems. Yext, Inc. (NYSE: YEXT), the leading...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised XinThera on the transaction. Gilead Sciences announced the acquisition of San Diego-based XinThera, a privately held biotech company. The acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ease on the transaction. Employee Navigator, the leading benefits administration and HR software solution for insurance brokers and employers, announced...
You must be a Standard 1 Year member to access this content.
Wilson, Sonsini is acting as legal counsel to Amphastar. Kirkland & Ellis and Covington & Burling are acting as legal counsel to Lilly. In an effort...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Caption Health on the acquisition. GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Bakkt on the deal. Digital asset platform Bakkt Holdings Inc. announced the acquisition of Apex Crypto LLC from Apex Fintech...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Enliven Therapeutics on the deal. Enliven Therapeutics, a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented J.P. Morgan Securities LLC as financial advisor to ForgeRock in the transaction. Wilson Sonsini advised ForgeRock. ForgeRock, Inc. (NYSE: FORG) (“ForgeRock”) announced its acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Misfits Market on the deal. Misfits Market, the online grocery platform driven by accessibility, affordability, and sustainability, announced the acquisition of online grocer...
You must be a Standard 1 Year member to access this content.
